ClinicalTrials.gg
Not yet recruitingNCT07908589Updated Nov 2, 2026

Tempo-controlled Low-load Resistance Training in Patients With Knee Osteoarthritis.

An interventional study of Tempo-controlled low-load resistance training and Conventional Physiotherapy Training in Knee Osteoarthritis, sponsored by University of Management and Technology Lahore. Not yet recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
All
01

Study summary

This randomized controlled trial aims to evaluate the effects of tempo-controlled low-load resistance training compared to conventional low-load resistance training on pain, muscle performance, and functional disability in patients with knee osteoarthritis. The study will recruit 32 participants aged 40-65 with Grade I-II knee osteoarthritis and randomly allocate them into two groups for a 6-week intervention at Ch Rehmat Ali Memorial Trust Hospital. Group A will perform strengthening exercises (such as sit-to-stand, mini squats, and leg raises) using a controlled 3-1-3 second tempo cadence (eccentric, isometric hold, concentric), while Group B will perform the same exercises at a self-selected speed; both groups will receive preparatory moist heat, warm-ups, knee isometrics, and Maitland mobilizations three times weekly. Primary outcomes-including pain intensity (NPRS), functional difficulty (WOMAC), walking endurance (6MWT), and mobility (TUG)-will be evaluated at baseline and 6 weeks to determine if tempo control offers a more effective, well-tolerated alternative for managing knee osteoarthritis.

02

Conditions studied

  • Knee Osteoarthritis

Keywords

  • Tempo-controlled resistance training
  • low- load resistance training
  • knee osteoarthritis
03

In context

Osteoarthritis, Knee

3,407 studies on the registry are indexed under Osteoarthritis, Knee; 638 are open to participants now.

This study's planned enrollment of 32 is below the median of 69 across 2,822 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 34 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Patients diagnosed with knee osteoarthritis according to clinical criteria. Age between 40-65 years. Both male and female participants. NPRS pain score between >3/10 and 6/10. Radiographic grade I-II knee osteoarthritis. Ability to walk independently without assistive device.

Exclusion criteria

Exclusion Criteria:

Recent knee surgery within the last six months. Inflammatory joint diseases such as rheumatoid arthritis. Severe diagnosed cardiovascular or neurological disorders. Intra-articular injections within previous three months. Uncontrolled hypertension or diabetes. Severe diagnosed knee deformities requiring surgical intervention. Cognitive impairment (Parkinson) affecting exercise participation.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
32 participants (estimated)

Study arms

  • Experimental
    Tempo-controlled low load resistance training

    Participants will receive a 10-minute moist heat application, followed by a 5-10-minute warm-up, knee isometric exercises, and Maitland mobilization. The intervention will include sit-to-stand, mini squats, straight leg raises, step-ups, terminal knee extensions, and seated knee extensions. Each exercise will be performed at a controlled tempo of 3 seconds eccentric, 1-second isometric hold, and 3 seconds concentric, with 3 sets of 10 repetitions and 1-minute rest intervals between sets. Exercise progression will be individualized according to patient tolerance.

    Other: Tempo-controlled low-load resistance training

  • Active comparator
    Conventional Physiotherapy Training

    Participants will receive the same initial physiotherapy treatment and strengthening exercises as Group A, but the exercises will be performed at a self-selected speed without tempo control. Each exercise will consist of 3 sets of 10 repetitions. Both groups will receive treatment three times per week for six weeks.

    Other: Conventional Physiotherapy Training

Interventions

  • OtherTempo-controlled low-load resistance training

    The intervention will include sit-to-stand, mini squats, straight leg raises, step-ups, terminal knee extensions, and seated knee extensions. Each exercise will be performed at a controlled tempo of 3 seconds eccentric, 1-second isometric hold, and 3 seconds concentric, with 3 sets of 10 repetitions and 1-minute rest intervals between sets. will receive treatment three times per week for six weeks.

  • OtherConventional Physiotherapy Training

    Participants will receive the same initial physiotherapy treatment and strengthening exercises as Group A, but the exercises will be performed at a self-selected speed without tempo control. Each exercise will consist of 3 sets of 10 repetitions and will receive treatment three times per week for six weeks.

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale (NPRS)

    The Numeric Pain Rating Scale (NPRS) is an 11-point numerical scale used to assess pain intensity. Scores range from 0, indicating no pain, to 10, representing the worst imaginable pain. Participants rate their perceived knee pain, and changes in scores are used to evaluate the effectiveness of the interventions in reducing pain intensity.

    Time frame: Baseline and after 6 weeks

  2. WOMAC Function Subscale

    The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) Function Subscale is a disease-specific questionnaire used to assess physical disability in patients with knee osteoarthritis. It evaluates the degree of difficulty experienced during daily activities, including stair climbing, sitting, standing, walking, and household tasks. Changes in scores indicate improvements or worsening in functional ability.

    Time frame: Baseline and after 6 weeks

  3. Six-Minute Walk Test (6MWT)

    The Six-Minute Walk Test is a functional performance test used to assess walking endurance and functional exercise capacity. Participants are instructed to walk as far as possible for six minutes, and the total distance covered is recorded in meters. An increase in walking distance indicates improved functional exercise capacity and mobility.

    Time frame: Baseline and after 6 weeks

  4. Timed Up and Go (TUG) Test

    The Timed Up and Go Test is a clinical assessment tool used to measure functional mobility and dynamic balance. Participants are instructed to rise from a chair, walk three meters, turn around, return to the chair, and sit down. The total time required to complete the task is recorded in seconds. A reduction in completion time generally indicates improved functional mobility and movement performance.

    Time frame: Baseline and after 6 weeks

07

Study locations

1 site
  • UMT
    Lahore, Punjab Province 54000, Pakistan
    • Fizza Masood Dr., MS-OMPT · Contactfizza.masood@umt.edu.pk · +923344318731
    • Rabia Jawa CoD Physical Therapy and Rehabilitation, MPhil PT · Contactrabia.jawa@umt.edu.pk · +923434570838
    • Omaima Rahim · Sub investigator
08

References and documents

Individual participant data

Plan to share: Yes — The results data collected , de-identified individual participant data will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: 6 months after the publication of the manuscript.

Access criteria: The data can be requested from the corresponding author

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

Of 1,149 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 2 months is below that.

Counting every sponsor, half of 1,292 studies reached it within 17 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Nov 2, 2026
StartEst.
Oct 27, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07908589
Lead sponsor
University of Management and Technology Lahore
Responsible party
Fizza Masood (Assistant Professor, University of Management and Technology Lahore) — Principal investigator
First posted
Nov 2, 2026
Start date
Oct 27, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 2, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion